Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective. (abre una nueva ventana)

Agreda-Vásquez GP, Espinosa-Poblano I, Sánchez-Guerrero SA, Crespo-Solís E, Cabrera-Vásquez S, López-Salmorán J, Barajas J, Peñaloza-Ramírez P, Tirado-Cárdenas N, Velázquez A.

Fuente‎: J Clin Apher 2008;23(5):163-7.

Indexado en‎: PubMed 18819155

DOI‎: 10.1002/jca.20175

https://www.ncbi.nlm.nih.gov/pubmed/18819155 (abre una nueva ventana)

Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (abre una nueva ventana)

Cid J, Ortín X, Elies E, Díaz E.

Fuente‎: Transfus Apher Sci 2003;28(1):101-2.

Indexado en‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (abre una nueva ventana)

Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature. (abre una nueva ventana)

Ellis J, Theodossiou C, Schwarzenberger P.

Fuente‎: Am J Med Sci 1999;318(3):190-3.

Indexado en‎: PubMed 10487410

https://www.ncbi.nlm.nih.gov/pubmed/10487410 (abre una nueva ventana)

Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium. (abre una nueva ventana)

Goss GA, Weinstein R.

Fuente‎: J Clin Apher 1999;14(3):114-21.

Indexado en‎: PubMed 10540365

https://www.ncbi.nlm.nih.gov/pubmed/10540365 (abre una nueva ventana)

Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis. (abre una nueva ventana)

Haupt WF, Rosenow F, van der Ven C, Birkmann C.

Fuente‎: Ther Apher 2000;4(3):195-7.

Indexado en‎: PubMed 10910018

https://www.ncbi.nlm.nih.gov/pubmed/10910018 (abre una nueva ventana)

Replacement fluids in plasmapheresis: cross-over comparative study. (abre una nueva ventana)

Le Conte P, Nicolas F, Adjou C, N'Guyen JM, Billaud E, Moreau P.

Fuente‎: Intensive Care Med 1997;23(3):342-4.

Indexado en‎: PubMed 9083239

https://www.ncbi.nlm.nih.gov/pubmed/9083239 (abre una nueva ventana)

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. (abre una nueva ventana)

Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.

Fuente‎: Ther Apher Dial 2004;8(3):248-53.

Indexado en‎: PubMed 15154879

DOI‎: 10.1111/j.1526-0968.2004.00138.x

https://www.ncbi.nlm.nih.gov/pubmed/15154879 (abre una nueva ventana)

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. (abre una nueva ventana)

Rock G, Sutton DM, Freedman J, Nair RC.

Fuente‎: J Clin Apher 1997;12(4):165-9.

Indexado en‎: PubMed 9483177

https://www.ncbi.nlm.nih.gov/pubmed/9483177 (abre una nueva ventana)